Riluzole for motor neurone disease. More trials are needed.

Riluzole for motor neurone disease. More trials are needed.

Detalles Bibliográficos
Autores principales:	Sandercock, J, Burls, A, Hyde, C, Fry-Smith, A, Barton, P, Bryan, S, Stewart, A
Formato:	Journal article
Lenguaje:	English
Publicado:	2001

Ejemplares similares

Riluzole for motor neurone disease [3] (multiple letters)
por: Sandercock, J, et al.
Publicado: (2001)

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.
por: Stewart, A, et al.
Publicado: (2001)

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: A rapid and systematic review
por: Stewart, A, et al.
Publicado: (2001)

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review
por: A. Stewart, et al.
Publicado: (2001-01-01)

Novel Tissue-Specific Multifunctionalized Nanotechnological Platform Encapsulating Riluzole Against Motor Neuron Diseases
por: Esteruelas G, et al.
Publicado: (2025-02-01)

Assessing the Effect of Riluzole on Motor Unit Discharge Properties
por: Ehsan Shandiz, et al.
Publicado: (2024-10-01)

Activation of TREK currents by riluzole in three subgroups of cultured mouse nodose ganglion neurons.
por: Diego Fernández-Fernández, et al.
Publicado: (2018-01-01)

The Effects of Riluzole on Cisplatin-induced Ototoxicity
por: Selin Üstün Bezgin, et al.
Publicado: (2019-03-01)

Riluzole Administration to Rats with Levodopa-Induced Dyskinesia Leads to Loss of DNA Methylation in Neuronal Genes
por: Luca Pagliaroli, et al.
Publicado: (2021-06-01)

NU-9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone
por: Barış Genç, et al.
Publicado: (2022-03-01)

Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease
por: Emma Hockly, et al.
Publicado: (2006-01-01)

Riluzole Ameliorates Harmaline-Induced Tremor in Rat
por: Fatemeh Rahimi Shourmasti, et al.
Publicado: (2014-05-01)

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study
por: Introna A, et al.
Publicado: (2018-01-01)

Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
por: Brañas, et al.
Publicado: (2000-01-01)

N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis
por: Jaejeong Kim, et al.
Publicado: (2023-11-01)

Are systematic reviews more cost-effective than randomised trials?
por: Glasziou, P, et al.
Publicado: (2006)

Blockade of persistent sodium currents contributes to the riluzole-induced inhibition of spontaneous activity and oscillations in injured DRG neurons.
por: Rou-Gang Xie, et al.
Publicado: (2011-01-01)

Brain and Plasma Riluzole Pharmacokinetics: Effect of Minocycline Combination
por: Aline Milane, et al.
Publicado: (2009-08-01)

Controlling the Solubility, Release Rate and Permeation of Riluzole with Cyclodextrins
por: Tatyana Volkova, et al.
Publicado: (2024-06-01)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus
por: Dretzke, J, et al.
Publicado: (2004)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus.
por: Dretzke, J, et al.
Publicado: (2004)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus.
por: Dretzke, J, et al.
Publicado: (2004)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus
por: J Dretzke, et al.
Publicado: (2004-06-01)

Analysis of riluzole’s profile of use in a Central Hospital in Lisbon
por: Paróla A, et al.
Publicado: (2018-11-01)

Use of Riluzole for the Treatment of Hereditary Ataxias: A Systematic Review
por: Iván Nicolas Ayala, et al.
Publicado: (2022-08-01)

Riluzole use in presence of contraindications in adults affected by amyotrophic lateral sclerosis and its off-label use in other motor neuron diseases: Findings from an Italian multicentre study (the CAESAR project)
por: Giada Crescioli, et al.
Publicado: (2022-10-01)

Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis
por: Dyer AM, et al.
Publicado: (2016-12-01)

Functional connectivity–based prediction of global cognition and motor function in riluzole-naive amyotrophic lateral sclerosis patients
por: Luqing Wei, et al.
Publicado: (2022-02-01)

Efficacy and safety of riluzole for treating motor function in rare dyskinesia syndromes: a systematic review with meta-analysis
por: Rui Wang, et al.
Publicado: (2024-09-01)

Treatments for fatigue in multiple sclerosis: A rapid and systematic review
por: Branas, P, et al.
Publicado: (2000)

Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
por: Brañas, P, et al.
Publicado: (2000)

The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe
por: Albert C. Ludolph, et al.
Publicado: (2023-12-01)

Structural identification of riluzole-binding site on human TRPC5
por: Yaxiong Yang, et al.
Publicado: (2022-07-01)

Structural basis for the rescue of hyperexcitable cells by the amyotrophic lateral sclerosis drug Riluzole
por: David Hollingworth, et al.
Publicado: (2024-09-01)

Congratulations to the NZMJ for the Unfortunate Experiment theme issue.
por: Sandercock, J, et al.
Publicado: (2010)

Decision-making under conditions of uncertainty-what can we learn from palivizumab?
por: Burls, A, et al.
Publicado: (2011)

How to make a compelling submission to NICE: tips for sponsoring organisations.
por: Burls, A, et al.
Publicado: (2003)

Decision-making under conditions of uncertainty-what can we learn from palivizumab?
por: Burls, A, et al.
Publicado: (2011)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
por: Burls, A, et al.
Publicado: (2002)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
por: Burls, A, et al.
Publicado: (2002)